Show simple item record

Can ebselen prevent cisplatin-induced ovarian damage?

dc.contributor.authorBayindir, Nihan
dc.contributor.authorUzun, Hafize
dc.contributor.authorEŞREFOĞLU, MUKADDES
dc.contributor.authorBORAN, Birtan
dc.contributor.authorSOYMAN, Zeynep
dc.date.accessioned2021-03-03T10:09:46Z
dc.date.available2021-03-03T10:09:46Z
dc.date.issued2018
dc.identifier.citationSOYMAN Z., Uzun H., Bayindir N., EŞREFOĞLU M., BORAN B., "Can ebselen prevent cisplatin-induced ovarian damage?", ARCHIVES OF GYNECOLOGY AND OBSTETRICS, cilt.297, sa.6, ss.1549-1555, 2018
dc.identifier.issn0932-0067
dc.identifier.otherav_210a9d15-b2ef-4e22-bbc9-2d421162f347
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/27256
dc.identifier.urihttps://doi.org/10.1007/s00404-018-4750-4
dc.description.abstractPurpose The occurrence of ovarian damage is a major shortcoming in treating tumors with cisplatin (CP). The present study investigates the beneficial effects of ebselen-a seleno-organic compound with antioxidant and antiinflammatory properties-vis-a-vis CP-induced ovarian damage.
dc.language.isoeng
dc.subjectKadın Hastalıkları ve Doğum
dc.subjectCerrahi Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectKADIN HASTALIKLARI & DOĞUM
dc.titleCan ebselen prevent cisplatin-induced ovarian damage?
dc.typeMakale
dc.relation.journalARCHIVES OF GYNECOLOGY AND OBSTETRICS
dc.contributor.departmentIstanbul Training & Research Hospital , ,
dc.identifier.volume297
dc.identifier.issue6
dc.identifier.startpage1549
dc.identifier.endpage1555
dc.contributor.firstauthorID19640


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record